内分泌治疗，可减少局部复发。
术后均接受放疗、化疗及内分泌治疗。
They all received radiotherapy, chemotherapy and endocrine treatment after operation.
结果全组均行手术治疗辅以内分泌治疗。
Results All of the 113 patients received operation and TSH suppression therapy.
目的观察胃癌患者化学内分泌治疗的效果。
Objective To observe the effects of chemo-endocrine therapy on gastric carcinoma (GC).
术后常规行辅助放疗、化疗和内分泌治疗。
Routine adjuvant irradiation, chemotherapy and hormone therapy were given postoperatively.
术后常规行辅助放疗、化疗和内分泌治疗。
Adjuvant irradiation, chemotherapy and hormone therapy were given postoperatively.
确定新的治疗靶点、提高内分泌治疗成功率至关重要。
It is crucial to identify novel targets for therapeutic intervention and improve the success of endocrine therapies.
背景化疗和内分泌治疗在乳腺癌内科治疗中有重要的价值。
BACKGROUNDChemotherapy and incretion treatment play a key role in the treatment of breast cancer.
目的探讨术前新辅助内分泌治疗在老年乳腺癌治疗中的意义。
Objective To study the curative effect of preoperative endocrine therapy on breast cancer in elderly women.
对大多数患者而言，内分泌治疗引起肿瘤缩小，有时效果非常明显。
For most patients, this hormone deprivation therapy causes tumors to shrink, sometimes dramatically.
结论ER、PR是用于判断预后、指导内分泌治疗的一项重要指标。
Conclusions ER and pr are important indexes for judging prognosis and directing endocrine treatment.
随着新的内分泌药物的出现，乳腺癌的内分泌治疗也取得了新的进展。
The endocrine therapy for breast cancer has made progress with the development of new endocrine drugs.
随着新的内分泌药物的出现，乳腺癌的内分泌治疗也取得了新的进展。
The endocrine therapy for breast cancer has made progress with the development of new endocrine drugs.
结果23例患者均行保乳手术，术后均辅以化疗、放疗或内分泌治疗等。
Results 23 patients were performed the breast surgery, who with the complementary with chemotherapy and radiotherapy or endocrine therapy.
来自临床试验的最初结果建议这些代理人将成为将来的内分泌治疗的基础。
Initial results from clinical trials suggest that these agents will become the cornerstones of future endocrine therapy.
虽然内分泌治疗加放疗显著地增加了一些与治疗相关的症状，但都不严重。
Although addition of radiotherapy to endocrine treatment significantly increased some treatment-related symptoms, none were serious.
术后辅助内分泌治疗联合放疗的综合治疗可显著延长无生化复发生存时间。
Multi-modal treatment like adjuvant androgen deprivation therapy plus radiotherapy can greatly improve the biochemical recurrence-free survival.
结论年龄并不是乳腺癌根治术的禁忌，且老年患者从辅助内分泌治疗中获益较多。
Conclusion Age is not the taboo of radical mastectomy, and elderly patients benefit from adjuvant endocrine therapy for more.
对晚期的乳腺癌患者，经过化疗和内分泌治疗后，5年生存率仍可达到25%以上。
To the later period breast cancer patient, after passing through the chemotherapy and the endocrine treatment, 5 year survival rate still might achieve above 25%.
这项研究结果也显示，相比较新辅助化疗，罕见对新辅助内分泌治疗有完全的缓解。
The results also indicate that a complete response to neoadjuvant endocrine therapy is rare compared to neoadjuvant chemotherapy.
治疗则根据原发肿瘤的化疗及内分泌治疗等，对局部病变也可选用放疗或外科手术。
The treatment consisted of chemotherapy and (or) hormonal therapy for the primary tumor and radiation therapy or surgical management of the metastatic lesion.
目的分析调强适形放射治疗(IMRT)联合内分泌治疗对中晚期前列腺癌的治疗效果。
Objective To evaluate the therapeutic effects of intensity modulated radiation therapy (IMRT) in combination with hormonotherapy in the treatment of intermediate and advanced prostate carcinoma.
内分泌治疗是激素受体阳性乳腺癌综合治疗的重要组成部分，其疗效已得到广泛的认可。
Endocrine therapy with certain effect is an important part of combined therapy for hormone receptor-positive breast cancer.
随着新的内分泌治疗药物的不断研发，激素受体阳性乳腺癌的内分泌治疗疗效逐渐提高。
As new drugs of endocrine therapy are found and used, the effect of endocrine therapy for hormone receptor positive breast cancer is more and more increased.
到目前为止，手术、放疗、化疗、内分泌治疗已并列成为乳腺癌确有疗效的四大治疗手段。
So far, the surgery, the radiotherapy, the chemotherapy, the endocrine treatment compound have become breast cancer to really have the curative effect four big treatment method.
术前辅以新辅助化疗，术后辅以正规内分泌治疗是提高局部晚期乳腺癌生存率的必要手段。
The neoadjuvant chemotherapy and regular endocrine therapy are the necessary measures to improve the survival rates of locally advanced breast cancer.
结论术前新辅助内分泌治疗在高龄乳腺癌患者中能达到原发病灶和区域淋巴结降期的目的。
Conclusion Preoperative endocrine therapy for breast cancer of elderly women could effectively delay or remit the advancement of the tumor.
内分泌治疗的远期影响仍然是一个问题，这是因为乳腺癌存活者的人数以及辅助治疗的持续时间都在增长。
The long-term impact of these endocrine manipulations is an issue, because the duration of adjuvant treatment is still increasing, as is the number of breast cancer survivors.
日前，约翰·霍普金斯的研究者发现在内分泌治疗无反应的患者的前列腺癌细胞的激素受体存在明显的差异。
Now, researchers at Johns Hopkins have discovered critical differences in the hormone receptors on prostate cancer cells in patients who no longer respond to this therapy.
方法对5 7例临床早期乳腺癌行局部广泛切除术、全腋淋巴结清扫术加术后放疗，并辅以化疗、内分泌治疗。
Methods 57 cases of early breast carcinoma were treated by wide local excision, axillary nodes dissection and postoperative radiotherapy. All patients received chemotherapy and endocrinotherapy.
应用推荐